The rate of procaine hydrolysis in serum of normal subjects and diseased patients. 1972

M M Reidenberg, and M James, and L G Dring

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011343 Procaine A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016). Anuject,Geriocaine,Gerokit,Hewedolor-Procain,Lophakomp-Procain N,Novocain,Novocaine,Procain Braun,Procain Jenapharm,Procain Rödler,Procain Steigerwald,Procain curasan,Procaina Serra,Procaine Hydrochloride,Pröcaine chlorhydrate Lavoisier,Röwo Procain,procain-loges,Hydrochloride, Procaine
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002802 Cholinesterases Acylcholineacylhydrolase,Cholase,Cholinesterase
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

M M Reidenberg, and M James, and L G Dring
January 1953, The Journal of clinical endocrinology and metabolism,
M M Reidenberg, and M James, and L G Dring
April 1953, Bollettino della Societa italiana di biologia sperimentale,
M M Reidenberg, and M James, and L G Dring
May 1987, Rinsho byori. The Japanese journal of clinical pathology,
M M Reidenberg, and M James, and L G Dring
January 1959, Arztliche Wochenschrift,
M M Reidenberg, and M James, and L G Dring
March 1951, Archives internationales de pharmacodynamie et de therapie,
M M Reidenberg, and M James, and L G Dring
May 1972, Clinical science,
M M Reidenberg, and M James, and L G Dring
November 1985, La Tunisie medicale,
M M Reidenberg, and M James, and L G Dring
July 1976, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
M M Reidenberg, and M James, and L G Dring
November 1988, Research in veterinary science,
M M Reidenberg, and M James, and L G Dring
January 2009, Computers in biology and medicine,
Copied contents to your clipboard!